EPO Patents = 5

Forward Citations = 16

Loading Chart...

15 inventors (with patents filed for the assignee):

Ada Funaro (3 out of 4 patents)

Santo Landolfo (2 out of 5 patents)

Giorgio Gribaudo (2 out of 3 patents)

4. Catherine Deloche (1 out of 8 patents)

5. Jean-Marc Combette (1 out of 8 patents)

6. Claire Abadie (1 out of 4 patents)

7. Massimo Clementi (1 out of 11 patents)

8. Robert Anthony Williamson (1 out of 13 patents)

9. Roberto Burioni (1 out of 12 patents)

10. Francesco Novelli (1 out of 2 patents)

11. Barbara Tomaino (1 out of 2 patents)

12. Paola Cappello (1 out of 2 patents)

13. Gianni Garotta (1 out of 4 patents)

14. Marianne Murphy (1 out of 1 patent)

15. Robert Anthony Williamson (0 patent)

6 patents: Sort by Forward Citations

1. 8747856 - Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases (2014-06-10),

2. 8338172 - Methods for obtaining immortalized antibody secreting cells (2012-12-25),

3. 8202518 - Antibodies against human cytomegalovirus (HCMV) (2012-06-19),

4. 8153129 - Antibodies against human cytimegalovirus (HCMV) (2012-04-10),

5. 8071721 - Antigens and antibodies associated to pancreatic ductal adenocarcinoma (2011-12-06),

6. 7811973 - Phage display technologies (2010-10-12),

Ribovax Biotechnologies S.a. is a leading biotechnology company specializing in the development of innovative vaccines and therapeutics. With a focus on RNA-based technologies, Ribovax is revolutionizing the way infectious diseases are prevented and treated. Our team of experts is dedicated to advancing the field of biotechnology and improving global health outcomes through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#2 in Petit-Lancy

#2,439 in Switzerland

Petit-Lancy, Switzerland

Ribovax Biotechnologies S.a.